Enovis CORP — Form 8-K
Filed August 6, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 42/100
What the filing says
Enovis reported Q2 2026 net sales of $583M (3% reported, 5% organic growth vs. Q2 2025). Reconstructive segment grew 8% reported / 6% organic; Prevention & Recovery declined 1% reported but grew 3% organic. Net loss was $1M ($0.02 per share); adjusted EBITDA $104M (17.9% margin); adjusted EPS $0.90. Company reaffirmed full-year 2026 guidance: revenue $2.31–2.37B (4–6% organic growth), adjusted EBITDA $425–435M, adjusted EPS $3.52–3.73, FCF conversion ≥25%.
Why this rating
Modest organic growth (5%) and stable margins offset by flat P&R segment. Guidance reaffirmation removes downside surprise but no upside catalyst. No major capital events, M&A, or restructuring. Execution-dependent update.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.